Dry Powder Aerosols: Emerging Technologies

Authored by: Hak-Kim Chan

Encyclopedia of Pharmaceutical Science and Technology

Print publication date:  July  2013
Online publication date:  July  2013

Print ISBN: 9781841848198
eBook ISBN: 9781351124874
Adobe ISBN:

10.1081/E-EPT4-v2-36

 Download Chapter

 

Abstract

Technology for inhalation drug delivery has been continually evolving over the past two decades. The current situation is that while nebulizers remain as a niche market for preferred users, major development has occurred in the propellant-driven metered-dose inhalers (MDIs) and particularly the dry powder inhalers (DPIs). For MDI, Stein and Fradley (2010) believed that “future MDIs will not be radically different from existing MDIs.” They predicted the future trend will be on the dose counters, canisters with internal coating to reduce drug adhesion, valves with fast fill and empty designs to minimize the need for priming, actuators with special mechanism to slow down the aerosol plume (thus reducing oropharyngeal deposition), novel elastomers to reduce leachables, new suspending agents, and engineered particles to improve formulation quality (1). In contrast, DPI technology is still undergoing a changing phase, and disruptive innovation is yet to appear in the scene. Development of DPI is particularly challenging involving production of fine drug particles, formulation approaches, inhaler device design, and interface with the patient usage. All of these areas are progressing with sustaining technologies toward personalized treatment in the future (2,3). This chapter will focus on some key aspects of the emerging technologies for the DPIs.

 Cite
Search for more...
Back to top

Use of cookies on this website

We are using cookies to provide statistics that help us give you the best experience of our site. You can find out more in our Privacy Policy. By continuing to use the site you are agreeing to our use of cookies.